#ICYMI At Climb Bio, we're dedicated to improving the lives of the approximately 50 million Americans—and countless others worldwide—living with immune-mediated diseases. ? Our new name, Climb Bio, reflects the journey each patient faces and our commitment to advancing transformative treatments. By harnessing new discoveries in molecular immunology and antibody engineering, and listening to the voices of scientists, physicians, and patients, we’re determined to make a real difference. ? Together, we’re climbing toward a future with better treatments and brighter outcomes. ? Watch the full replay of our Investor Day: https://lnkd.in/g4nVmyg5.
Climb Bio的动态
最相关的动态
-
??Meet us at BIO-EUROPE in Stockholm! ? Don’t miss the opportunity to connect with our CEO Michael Koslowski and CSO Stefano Gullà next week at #BIOEurope2024, from 4-6 November in Stockholm, Sweden! ? ?? Connect with Michael and Stefano onsite to learn more about the latest advancements on our clinically validated, primary B-cell selection and evolution platform technologies, Kling-Select and Kling-Evolve. ? #Kling's proprietary primary B-cell screening platform efficiently identifies therapeutic targets and antibodies from B-cells of ‘exceptional responders’, which, having been developed in the human body, have shown to be safe and effective in helping these individuals successfully battle illnesses including #cancer and #infectiousdiseases. ? Presented by Informa Connect and #EBDGroupPartnering, #BIOEurope has been where CEOs and investors gather to connect with professionals spanning the global life science ecosystem to propel dealmaking and innovation for more than 30 years, ? #drugdiscovery #immunooncology #antibodytherapeutics
-
-
?????????????? ?????? ???????????????? ?????????????? ???????? ???????????????????? ????????! ? Last week, we immersed ourselves in the 19th Annual Biomarkers Congress, delving into the latest trends and tools in biomarker research. Watch our attendees share their experiences in the Biomarkers 2024 post-event video below ?? If you're interested in joining us for Biomarkers 2025, find all the details here: https://hubs.la/Q02n1jr30 #OGBiomarkers #Biomarkers24
-
Meet my colleagues from InSilicoTrials at PAGE!
???? ??? ????! ?????????????? ?? ???? 2024 ?? June 26-28 | Rome ???????????????????????????? is excited to announce our participation at PAGE - Population Approach Group Europe 2024. Join us at the Ergife Hotel in Rome, Italy and get in touch with our team: ? ?? Mark Lovern will present a poster titled : ?????????????????????? ???????????????????????????? ???????????? ??????????????????: ??????????-?????????? ???????????????????? ???????? ?????? ???????????? ????????????. ?? Chiara Nicolò will also have a poster presentation: ???????????????????? ?????????????? ?????????????????? ????????-?????????????? ???????????????? ???????????? ?????????? ?????? ???????????????????????????? ??????????-?????????? ????????????????. ?? Daniel R?shammar will be speaking at the ?????????????????????? ?????????????????????????????? ???????????? ?????????????????? (????????) on June 25, 2024. This symposium is a satellite event of #PAGE2024 and offers an excellent opportunity to learn more about the world of #pharmacometrics. ? Looking forward to connecting with the PAGE community!
-
-
Check out our most recent blog! #MicrobiomeResearch #CancerResearch
-
????Day 1 at the ACGS Summer Scientific Meeting 2024 in Birmingham! ??Are you also attending #ACGS2024 ? Come meet our team Simona Sevdina and Tasos Kotzadamis and explore more about our mission of expanding access to data-driven medicine, leveraging the power of the SOPHiA DDM? Platform! ?? Join us in person and get a glimpse of how our platform enables clinical researchers to draw actionable insights across multiple disease areas – from oncology to rare and inherited disorders and more! #ACGS #datadrivenmedicine #AIinHealthcare #Genomics
-
-
CEO at Oslo Business Region - culture, innovation and entrepreneurship to create positive change. Global affairs | Talent attraction | Place |
?? Exciting things are happening in the #Nordic #health and #lifescience ecosystem. This week, 18-19 September, Oslo Business Region is at Nordic Life Science Days in Sweden together with key innovation hubs, Norway Health Tech, Oslo Cancer Cluster, Aleap, ShareLab, The Life Science Cluster and Oslo Science City. One of Oslo Business Region's missions is to attract more international talent to the health and life science sector. And 1600 professionals from over 30 countries gather in #Malm?. Together, we're showcasing Oslo’s cutting-edge companies, promoting #Oslo as an attractive destination to work and invest, and strengthening Nordic collaboration: ? health technology and digital health ? emerging startups ? cancer research and treatment ? bio tech innovation ? collaborative ecosystem We're excited to see the ideas, partnerships and connections that will come from this gathering of great people. ?? Reach out to Andrea Nylund and check out the overview of _some_ of the stakeholders (link in comments) if you're interested in opportunities in Oslo and Norway. #TalentAttraction #NLSDays #Innovation #NordicCollaboration Charlotte Homme Hanne Mette Kristensen Lena Nymo Helli Christine Wergeland S?rbye Ketil F. Widerberg Marius ?gaard Bj?rn Klem Wenche Gerhardsen Sindre Holme Trine Radmann Delphine Costa Monica Larsen Tone Varslot Stave Maria Cathrine Lundstad Aulie
Discover groundbreaking developments and meet key players from Oslo's health and life sciences ecosystem this week at Nordic Life Science Days (18-19 September)! #NLSDays Nordic Life Science Days https://hubs.li/Q02Q4hF90 Norway Health Tech, Oslo Cancer Cluster, Aleap, ShareLab, The Life Science Cluster, Oslo Science City
-
-
Truly comprehensive, differentiated AI foundation models for human cellular and tissue biology are a material breakthrough for advancing anti-cancer and related therapies Great to see this progress from DCVC-backed NOETIK
NOETIK is excited present results using our first-in-class foundation models of cell and tissue biology this Friday at #SITC24. Lacey Padrón (abstract #1231) will share a full stack view of our platform from data to discovery: https://lnkd.in/g2dXFthr Yu (Phoebe) G. (abstract #861) will share our work using multimodal foundation models to study the biology of Tertiary Lymphoid Structures (TLS): https://lnkd.in/g7c9uhyE For partnering/collaboration discussions, connect live with Shafique Virani, MD FRCS. https://lnkd.in/gpHCDpmn
Noetik Announces First-in-Class Human Foundation Models for Discovery at SITC 2024
businesswire.com
-
Next week I will be at Terrapinn #AdvancedTherapies 2024 in #London. Come visit us at S52 to hear more about our upcoming commercial launch of our offline benchtop cell analyzer. If you are working on T cells or cell differentiation, let's talk to see how we can help with some of your cell analytics! #cgt #cellanalysis
Cytomos is excited to give you a sneak-peek ?? at our new cell analysis and characterisation tech at Advanced Therapies 2024! Cells are the underlying basis of your CGT therapy, so whether you are developing a cell line for a viral vector or looking to detect cell phenotype changes earlier, you’ll want to see ?? what we’re bringing to the benchtop. ?? Come meet with David Rigterink, Fernanda Masri, and Kieran McDonald at S52. Sign up to stay in the loop for our upcoming product launch this summer! ?? #AdTherapies #advancedtherapies #CGT #PAT #cytometry
-
-
?????? ?????????? ???? ???????????????????? ?? Always looking forward to help the community of experts managing the diagnostic-therapeutic pathway of solid neoplasms where the presence of #DNA alterations makes patients eligible for treatment with molecular targeted drugs. Discover the full content here ?? https://lnkd.in/dBPCXJ5B
This happen when a group of collegues became a network of friends! all together working for our patients. https://lnkd.in/dsmbDDtA Biomarkers Atlas Silvia Novello @passiglia Francesco Pepe Pasquale Pisapia @marialuciareale Diego Cortinovis @fragetta Domenico Galetta Paolo Graziano @garbo Fabio Pagni Giulia Pasello Piovano Pier Luigi Sara Pilotto @tiseo @carlogenova @righi Giancarlo Troncone
-
-
Inoviv is proud to announce the launch of the FibroKey? Grant Program, designed to advance fibrosis research and support scientists worldwide. With this program, we’re providing access to our cutting-edge FibroKey? platform, enabling researchers to receive analysis on up to 75 human urine samples and generate valuable data to further therapeutic development. At Inoviv, collaboration and shared innovation are at the heart of scientific progress. Through the FibroKey? Grant Program, we’re committed to supporting the scientific community in making impactful advancements in #fibrosis research. Are you ready to take your fibrosis research to the next level? Apply now and be part of the future of fibrosis research. Learn more and apply - https://lnkd.in/gXZgphtD #FibrosisResearch #BiomarkerDiscovery #FibrosisTreatment #biomarkers #ChronicKidneyDisease #PharmaResearch #ClinicalResearch #BiotechInnovation #DrugDevelopment #Proteomics #FibrosisBiomarkers
FibroKey Grant Program - Inoviv
https://www.inoviv.com
